BC
HRTX icon

Boxer Capital’s Heron Therapeutics HRTX Stock Holding History

Boxer Capital’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-200,000
Closed -$3.45M – 32
2016
Q3 		$3.45M Buy
+200,000
New +$3.71M 1.54% 17

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM

Boxer Capital's HRTX Position: Q4 2016 in Review

Boxer Capital sold out of Heron Therapeutics (HRTX) in Q4 2016, closing a stake of 200,000 shares — an estimated $3.45M sold.

Boxer Capital first reported a position in HRTX in Q3 2016 and held it in 1 quarter. The position peaked at $3.45M in Q3 2016. 99 funds tracked by Wall St. Rank hold HRTX as of Q4 2016.

  • Boxer Capital reported no remaining Heron Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Boxer Capital sold 200,000 Heron Therapeutics shares in Q4 2016, an estimated $3.45M.
  • Boxer Capital first reported a position in Heron Therapeutics in Q3 2016 and held it in 1 quarter.
  • Boxer Capital's Heron Therapeutics position peaked at $3.45M in Q3 2016.
  • 99 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2016.

Based on Boxer Capital's 13F filing for Q4 2016, filed 14 Feb 2017.